Effects of different methods of double lumen endotracheal tube cuff deflating on patient's coughing during emergence

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200057904

Enrollment

Unknown

Registered

2022-03-21

Start date

2022-04-01

Completion date

Unknown

Last updated

2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung disease

Interventions

Experimental group:Slow deflation of endotracheal tube

Control group:rapid deflation of endotracheal tube

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65; 2. ASA Grade I-II; 3. Mallampati I-II level.

Exclusion criteria

Exclusion criteria: 1. History of hyperreactive airway diseases, such as COPD and asthma; 2. BMI greater than 30 kg/m2 or sleep apnea syndrome; 3. Preoperative history of high reflux aspiration risk; 4. Patients who take sedatives, antitussive drugs and ACEI drugs; 5. Recently infected with upper respiratory tract; 6. Severe heart disease; 7. Patients with a recent history of smoking.

Design outcomes

Primary

Measure	Time frame
Cough;Severity of cough;	—

Secondary

Measure	Time frame
vital signs;Sufentanil dosage;Remifentanil dosage;Dexmedetomidine dosage;Adverse reaction;	—

Countries

China

Contacts

Public ContactWang Jiang

The First Affiliated Hospital of Anhui Medical University

wangjiang59@126.com+86 15155373269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026